HSCYX
Price
$36.47
Change
-$0.38 (-1.03%)
Updated
Jul 31 closing price
Net Assets
674.29M
VEXPX
Price
$131.25
Change
-$0.36 (-0.27%)
Updated
Jul 31 closing price
Net Assets
23.31B
Interact to see
Advertisement

HSCYX vs VEXPX

HSCYX vs VEXPX Comparison Chart in %
View a ticker or compare two or three
VS
HSCYX vs. VEXPX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSCYX is a StrongBuy and VEXPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 23.3B vs. HSCYX (674M). VEXPX pays higher dividends than HSCYX: VEXPX (0.37) vs HSCYX (0.00). HSCYX was incepted earlier than VEXPX: HSCYX (30 years) vs VEXPX (59 years). HSCYX (0.99) is less costly to investors than VEXPX (0.39). HSCYX is a more actively managed with annual turnover of: 71.00 vs. VEXPX (51.00). VEXPX has a lower initial minimum investment than HSCYX: VEXPX (3000) vs HSCYX (250000). HSCYX annual gain was more profitable for investors over the last year : 25.54 vs. VEXPX (14.62). HSCYX return over 5 years is better than : -8.16 vs. VEXPX (-10.12).
HSCYXVEXPXHSCYX / VEXPX
Total Expense Ratio0.990.39254%
Annual Report Gross Expense Ratio0.990.39254%
Fund Existence30 years59 years-
Gain YTD11.39314.31980%
Front LoadN/AN/A-
Min. Initial Investment25000030008,333%
Min. Initial Investment IRAN/AN/A-
Net Assets674M23.3B3%
Annual Yield % from dividends0.000.37-
Returns for 1 year25.5414.62175%
Returns for 3 years46.1122.18208%
Returns for 5 years-8.16-10.1281%
Returns for 10 years86.8354.66159%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYWTX97.931.56
+1.62%
Rydex Emerging Markets 2X Strategy A
TVLAX12.630.05
+0.40%
Touchstone Value A
ETLNX16.860.06
+0.36%
Eventide Large Cap Focus N
JCMAX67.92-0.17
-0.25%
JPMorgan Mid Cap Equity A
ETCHX48.36-0.79
-1.61%
Eventide Healthcare & Life Sciences C